Ultrastructural localization of tyrosine hydroxylase in human peripheral blood mononuclear cells: effect of stimulation with phytohaemagglutinin by Reguzzoni, Marcella et al.
Abstract Using immunocytochemistry coupled to fluo-
rescence and electron microscopy, we investigated the
expression and ultrastructural localization of tyrosine hy-
droxylase (TH, EC 1.14.16.2), the rate-limiting enzyme
in the biosynthesis of catecholamines, in human periph-
eral blood mononuclear cells (PBMCs), with PC12 cells
as positive controls. In unstimulated PBMCs, TH-specif-
ic immunoreactivity was localized to the plasma mem-
brane. However, after stimulation with the polyclonal
mitogen phytohaemagglutinin (PHA), TH immunoreac-
tivity was almost completely localized to electron-dense
cytoplasmic granules, which resembled those found 
in PC12. TH-positive granules, however, were larger
(300–500 nm) than in PC12 cells (100–200 nm). Flow
cytometry analysis of TH expression showed about
46–50% positive cells in unstimulated PBMCs and in
PHA-stimulated PBMCs in the G0/G1 phase of the cell
cycle, but more than 80% positive cells in PHA-stimulat-
ed PBMCs in the S+G2/M phase. In agreement with pre-
vious observations, PHA stimulation also induced de
novo expression of TH mRNA as well as increased intra-
cellular catecholamine content, suggesting the occur-
rence of TH upregulation at the level of both gene ex-
pression and enzyme activity. The ultrastructural local-
ization of TH in human PBMCs seems therefore regulat-
ed by cell stimulation and related to the functional activi-
ty of the enzyme.
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Introduction
Although it is well established that sympathoadrenergic
mechanisms play a major role in the cross-talk between
the nervous system and the immune system (Friedman
and Irwin 1997; Elenkov et al. 2000), compelling evi-
dence that immune system cells themselves produce cat-
echolamines was given only a few years ago (Bergquist
et al. 1994; Musso et al. 1996; Marino et al. 1999). Im-
mune-cell-derived catecholamines may be relevant not
only for the neuroimmune network (Friedman and Irwin
1997; Elenkov et al. 2000), but also as autocrine/para-
crine factors, as suggested by the ability of adrenergic
antagonists to regulate macrophage production of tumor
necrosis factor-α (Spengler et al. 1994).
Pharmacological evidence suggests that catechol-
amine synthesis in immune cells is likely to occur
through the classical sympathoadrenergic pathways. In
the adrenal medulla and in catecholaminergic neurons
tyrosine hydroxylase (TH, EC 1.14.16.2) is the first and
rate-limiting enzyme in catecholamine synthesis (see,
e.g. Masserano et al. 1989). Inhibition of TH reduces in-
tracellular catecholamine levels in mouse lymphocytes
(Joseffson et al. 1996), macrophages (Spengler et al.
1994), and mast cells (Freeman et al. 2001), in human
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lymphocytes (Bergquist et al. 1994), in peripheral blood
mononuclear cells (PBMCs; Musso et al. 1996; Marino
et al. 1999; Cosentino et al. 2000), and even in hemato-
poietic cell lines (Cosentino et al. 2000). Since TH con-
trols the rate of catecholamine synthesis also in immune
cells, studying the regulatory mechanisms of TH in these
cells should contribute to a better understanding of the
role(s) of immune-cell-derived catecholamines.
Evidence exists that in adrenal medulla, sympathetic
nerves and brain (notably in the striatum), TH may exist
in a soluble, less active form and in a membrane-bound,
more active form. The ultrastructural localization of TH
has been suggested to play a role in the regulation of cat-
echolamine synthesis. In rat adrenal medulla, the stress-
induced activation of TH was associated with a shift in
the subcellular distribution of the enzyme from the cyto-
sol to membranous structures. In agreement with these
results, a marked increase in the enzyme activity was
produced by incubation of TH with isolated chromaffin
granule membranes or with the cytoskeletal component
G-actin. This issue has been extensively reviewed by
Masserano and coworkers (1989).
Few data exist at present concerning the ultrastructur-
al localization of TH in immune cells. The expression of
TH was shown by flow cytometry in various immune
cell lines (Tsao et al. 1998) and recently by confocal la-
ser microscopy TH immunoreactivity was found to be
diffused to cytoplasm and plasma membrane of human
lymphocytes (Amenta et al. 2001). Human PBMCs,
however, were previously reported to express no detect-
able levels of TH mRNA (Miyajima et al. 1995), a find-
ing which indirectly suggests that in these cells the en-
zyme may be highly stable. Indeed, increasing the intrin-
sic activity of TH has been shown to decrease the half-
life of the enzyme (reviewed by Kumer and Vrana 1996).
In this regard, some of us have recently shown that stim-
ulation of human PBMCs with the polyclonal mitogen
phytohaemagglutinin (PHA) induces a dramatic increase
in the production of catecholamines, which is preceded
by the expression of TH mRNA (Cosentino et al. 2002).
Based on these findings, it is conceivable that stimula-
tion of PBMCs leads to increased turnover of TH as a re-
sult of increased activity of the enzyme.
The present study was therefore undertaken to exam-
ine the ultrastructural localization of TH in human
PBMCs and to test the possibility that in PBMCs TH ac-
tivation may correspond to a subcellular redistribution of
the enzyme.
Materials and methods
Cells
Human PBMCs were isolated from venous blood obtained from
healthy volunteers using heparinized tubes. Whole blood was al-
lowed to sediment on dextran at 37°C for 30 min. Supernatant was
recovered and PBMCs were separated by density-gradient centrif-
ugation using Ficoll-Paque Plus. Cells were then washed 2 times
in NaCl 0.15 M and resuspended at a final concentration of
1×106 cells/ml in RPMI 1640 medium supplemented with 10%
heat-inactivated fetal calf serum, 2 mM glutamine and 100 U/ml
penicillin-streptomycin, at 37°C, in a moist atmosphere of 5%
CO2. Typical PBMC preparations contained about 80% lympho-
cytes and 16% monocytes. Cell viability, assessed by the trypan
blue exclusion test, was always >99%. PBMCs were cultured for
48 h in the presence of PHA at a concentration of 10 µg/ml, a
treatment which in previous experiments was shown to induce a
maximal increase in intracellular catecholamines (Cosentino et al.
2002). Rat pheochromocytoma cells (PC12) used as positive con-
trols were obtained from the Interlab Cell Line Collection of the
National Institute for Cancer Research/Advanced Biotechnology
Center of Genoa, Italy. Cells were cultured in RPMI 1640 medium
supplemented with 10% heat-inactivated fetal horse serum, 5%
heat-inactivated fetal calf serum, 2 mM glutamine, and 100 U/ml
penicillin-streptomycin at 37°C in a moist atmosphere of 5% CO2.
Light-microscopic immunocytochemistry
Cells were smeared, air dried and fixed in 70% ethanol solution.
After 1 h permanence in phosphate-buffered saline (PBS) 0.1 M
containing 1% bovine serum albumin and 0.03% saponin, the
smears were incubated with mouse anti-TH monoclonal antibody
(Chemicon, Temecula, CA) 1:300 overnight at 4°C in a dark hu-
mid chamber. After three washes in PBS the slides were incubated
with goat anti-mouse IgG fluorescein isothiocyanate (FITC)-
labelled antibody (Molecular Probes Inc., Eugene, OR) 1:200 for
1 h at room temperature. Finally, the cells were washed and treat-
ed with streptavidin FITC-conjugated (Caltag Laboratories)
1 µg/106 cells for 30 min at 4°C in the dark. The slides were then
washed 3 times in PBS and mounted in glycerol. All observations
were performed with a Nikon Eclipse E600 microscope at
450–490 nM wavelength.
Electron-microscopic immunocytochemistry
After centrifugation at 1,000 g for 5 min, cells were fixed in 0.5%
paraformaldehyde and 0.2% glutaraldehyde in 0.1 M PBS
(pH 7.6) for 1 h at room temperature. Cells were then fixed in
2.5% buffered glutaraldehyde for 1 h, postfixed in PBS with added
OsO4 1% and stained with lead citrate and uranyl acetate accord-
ing to Reynolds (1963) to enhance image definition. Lead/uranyl
staining, however, was omitted in preparations subsequently la-
belled for TH, to avoid false positivity. Before labelling for TH,
cells were washed 3 times in PBS treated with H2O2 3% in PBS
for 30 min to inhibit endogenous peroxidases. Cells were then in-
cubated with mouse anti-TH monoclonal antibody (Chemicon,
Temecula, CA) 1:200 overnight at 4°C in PBS containing saponin
0.03%. Normal goat serum 1% was always added to prevent non-
specific binding of the antibody. The anti-TH antibody was dem-
onstrated by the avidin-biotin-peroxidase method (ABC kit, Vec-
tor Laboratories, Burlingame, CA) in TRIS buffer 0.05 M (pH 7.6)
with added H2O2 0.3% for 10 min at room temperature, using di-
aminobenzidine as a chromogen. Both TH-labelled and unlabelled
cells were further fixed in glutaraldehyde 2.5% for 1 h, postfixed
in OsO4 1%, briefly dehydrated in graded ethanol and propylene
oxide and embedded in Epon 812. Ultrathin sections were cut,
fixed in 2.5% buffered glutaraldehyde for 1 h, postfixed in OsO4
1% and observed without overstaining under an electron micro-
scope (Jem-1010, JEOL, Akishima, Japan). Specificity of label-
ling was assessed by either omitting the incubation step with the
anti-TH antibody (negative control) or substituting the anti-TH an-
tibody with a mouse monoclonal IgG2a with irrelevant specificity
(Immunotech, Marseille, France; isotypic control). In neither case
could significant diaminobenzidine deposition be observed.
Flow cytometry analysis of TH expression
TH in human PBMCs was labelled by using an indirect immuno-
fluorescence method. Briefly, cells were centrifuged, resuspended
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in phosphate-buffered saline, fixed and permeabilized with ethanol
70% (4°C, 40 min). Cells were then rinsed and incubated with
mouse anti-TH monoclonal antibody (0.8 µg/106 cells; Chemicon,
Temecula, CA) for 30 min at 4°C. Subsequently, the cells were
washed and treated with biotin-labelled goat anti-mouse antibody
(2 µg/106 cells; Caltag Laboratories, Burlingame, CA) for 30 min
at 4°C. Finally, the cells were washed and treated with streptavidin
FITC conjugated (1 µg/106 cells, Caltag Laboratories, Burlingame,
CA) for 30 min at 4°C in the dark. Since immune cells may ex-
press receptors for the Fc of antibodies, preliminary experiments
with an isotypic control (mouse monoclonal IgG2a with irrelevant
specificity, Immunotech, Marseille, France) were performed on
human PBMCs to exclude non-specific binding by the anti-TH an-
tibody. In each analysis, samples of the same specimens were pro-
cessed omitting the incubation step with the anti-TH antibody and
used as a negative control, and 10,000 cells/sample were analysed.
A typical flow cytometric analysis of TH expression in unstimu-
lated PBMCs (and, for comparison, in PC12 cells) is shown in
Fig. 1. In some experiments the expression of TH was analysed to-
gether with cell cycle. To this end, after TH labelling cells were
washed and incubated with 1 ml PBS containing propidium iodide
(PI, 50 µg/ml; Sigma-Aldrich Inc., St. Louis, MI) and RNAse
(0.2 mg/ml; Sigma-Aldrich Inc., St. Louis, MI) for 1 h at 4°C in
the dark, and 25,000 cells/sample were analysed. The cell-associ-
ated fluorescence analysis was performed by using a Coulter Epics
Elite ESP flow cytometer (Beckman-Coulter, Miami, FL). Cell
fluorescence was quantified by using the mean channel fluores-
cence intensity (MFI), i.e. the median value of fluorescence inten-
sity distribution. Results were then expressed both as MFI and as
MFI ratio (i.e. MFI of anti-TH antibody-treated cells/MFI of nega-
tive controls).
RNA isolation and RT-PCR analysis 
of tyrosine hydroxylase mRNA
Total RNA was extracted from 1×106 PBMCs using the Perfect
RNA Eukaryotic Mini kit (Eppendorf, Hamburg, Germany). The
kit uses a chaotropic guanidinium isothiocyanate solution for cell
lysis and rapid inactivation of cellular RNAses. RNA is subse-
quently bound to the matrix of the column, washed to remove con-
taminants and then eluted with molecular biology grade water.
The amount of extracted RNA was estimated by spectrophotome-
try at 260 nm. Total RNA was reverse transcribed and cDNA was
amplified using a one-step reverse transcriptase polymerase chain
reaction (RT-PCR) reaction kit (Finnzymes, Espoo, Finland).
Twenty-five cycles of PCR were then performed according to the
following steps: 48°C, 30 min (once); 94°C, 1 min; 55°C, 1 min;
and 72°C, 2 min. At the end, the reaction mixture was kept for
5 min at 72°C and finally chilled at –4°C until analysis, which was
performed on a 10-µl aliquot of the PCR product by electropho-
retical separation on a 2% agarose gel and subsequent visualiza-
tion by ethidium bromide staining (Biorad, Hercules, CA). For se-
lection of the primers, we referred to the National Center for Bio-
technology Information database. The primers’ sequences were as
follows: 5′-primer, sense (exon 5) 5′-TGTCAGAGCTGGACAA-
GTGT-3′, and 3′-primer, antisense (exon 8) 5′-GATATTGTCTTC-
CCGGTAGC-3′. In the presence of TH mRNA, a 299-basepair
cDNA fragment was expected to be amplified.
HPLC-ED analysis of intracellular catecholamines
Intracellular catecholamines were assayed by high-performance liq-
uid chromatography (HPLC) with electrochemical detection (ED)
according to a previously described method (Marino et al. 1997).
Results
Light-microscopic immunocytochemistry
In both unstimulated and PHA-stimulated PBMCs, specif-
ic immunofluorescence for TH was evident in about 50%
of the cells. However, in unstimulated cells fluorescence
was confined to the cell membrane while in PHA-stimu-
lated cells it was also present in the cytoplasm (Fig. 2).
Electron-microscopic immunocytochemistry
In agreement with previous classical observations (Bessis
1972), unstimulated PMBCs usually showed a large,
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Fig. 1 Representative flow cytometric analysis of TH expression
in human PBMCs. TH was labelled by using an indirect immuno-
fluorescence method with the biotin-streptavidin system for the
amplification of the signal. Data display TH expression as fluores-
cence intensity of FITC in arbitrary units. Filled histogram TH-
labelled cells (i.e. cells labelled with mouse anti-TH mAb fol-
lowed by goat anti-mouse IgG-biotin and streptavidin-FITC);
open histograms with solid line negative control (i.e. cells labelled
with goat anti-mouse IgG-biotin and streptavidin-FITC only);
open histogram with dotted line isotypic control (i.e. cells labelled
with a mouse monoclonal IgG2a with irrelevant specificity fol-
lowed by goat anti-mouse IgG-biotin and streptavidin-FITC). In-
set: Flow cytometric analysis of TH expression in PC12 cells
(filled histogram TH-labelled cells; open histogram negative con-
trol). For further details, see “Materials and methods”
Fig. 2A, B Light micrographs of human PBMCs labelled for TH.
In the absence of stimulation (A), about 50% of the cells showed
specific immunofluorescence for TH in the outer cytoplasm near
the cell membrane. However, after stimulation with PHA (B),
membrane-associated fluorescence disappeared and a similar per-
centage of cells exhibited diffused TH-specific immunofluores-
cence to the cytoplasm. Scale bars 10 µm
roundish nucleus surrounded by scarce cytoplasm, with
various mitochondria and free ribosomes. In some sec-
tions, rough reticulum and Golgi apparatus could be ob-
served (Fig. 3A). In these cells, specific immunoreactivi-
ty for TH was evident as an electron-dense positivity just
under the plasma membrane and in very thin cisternae
pertaining to the smooth reticulum underlying the plas-
ma membrane (Fig. 3B).
After PHA stimulation, most of the PMBCs main-
tained their integrity; however, in such preparations cy-
toplasmic fragments were also evident. PHA-stimulated
PMBCs were usually larger, with roundish nuclei often
showing a crown of dense chromatin near the nuclear en-
velope. The cytoplasm contained many free ribosomes
and the smooth endoplasmic reticulum was organized in
cisternae and post-Golgian vesicles. Smaller (200–
250 nm) vesicles showed an electron-transparent con-
tent, while the larger (300–500 nm) ones had an elec-
tron-dense, flocculent core. Larger vesicles were more
often localized in the periphery of the cytoplasm. The
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Fig. 3A, B Electron micrographs of human PBMCs. A Cell
stained with lead citrate and uranyl acetate to enhance image defi-
nition; B unstained cell labelled for TH. In TH-positive cells,
marked electron-dense positivity was visible near the plasma
membrane and in the underlying thin cisternae pertaining to the
smooth reticulum (arrow). Lead/uranyl staining was omitted to
avoid false positivity. Scale bars 1 µm
Fig. 4A–C Electron micrographs of human PBMCs after stimula-
tion with PHA. A Cell stained with lead citrate and uranyl acetate.
B Unstained cell labelled for TH. In TH-positive cells stimulated
with PHA, specific immunoreactivity for TH was almost exclu-
sively localized to large, electron-dense cytoplasmic granules (as-
terisks). C Detail of TH-positive cytoplasmic granules (asterisks).
TH-positive granules could occasionally be observed near the
plasma membrane, which was, however, always free from immu-
noreaction. Scale bars 2 µm (A), 1 µm (B), 500 nm (C)
mitochondria usually presented many thin cristae
(Fig. 4A). In PHA-stimulated PBMCs, specific immuno-
reactivity for TH was almost completely localized to
larger (300–500 nm), electron-dense cytoplasmic gran-
ules which could be occasionally observed also in close
proximity to the plasma membrane (Fig. 4B). At vari-
ance with unstimulated cells, after PHA stimulation plas-
ma membranes and periplasmalemmal smooth reticulum
cisternae showed no detectable TH immunoreactivity
(Fig. 4C).
For comparison, PC12 cells contained round, oval or
irregularly shaped granules with variable electron densi-
ties. Granules were about 100–200 nm in size with a
very electron-dense core and were usually localized at
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Fig. 5A–C Electron micrographs of PC12 cells. A Cell stained
with lead citrate and uranyl acetate. B Unstained cell labelled for
TH. TH-positive granules (arrows) quite homogeneous in size
were visible at the periphery of the cytoplasm. C Detail of TH-
positive granules (asterisks). TH-specific immunoreactivity was
localized to cytoplasmic granules near the plasma membrane,
which was completely free from TH-specific labelling. Scale bars
1 µm (A, B), 100 nm (C)
Fig. 6 Unstimulated human PBMCs (left) were about 50% posi-
tive for TH (A), but did not express TH mRNA (B) and contained
low levels of catecholamines (C). On the contrary, after 48 h stim-
ulation with PHA, 10 µg/ml (right) positivity for TH increased in
relationship with the cell cycle (A), TH mRNA could be detected
(B) and intracellular catecholamines increased about 20- to 
40-fold (C). A 1 TH-positive cells, 2 G0/G1 cells, 3 S+G2/M
cells. Data from one representative of ten experiments. B M mo-
lecular weight markers, N negative control (no RNA), lane 1 PC12
cells, lane 2 human PBMCs. Data from one representative of six
experiments. C empty columns dopamine, hatched columns nor-
epinephrine, filled columns epinephrine. Data are means ± SD of
six experiments
the periphery of the cytoplasm, immediately under the
plasma membrane (Fig. 5A). Strong and uniform TH im-
munoreactivity was seen in these granules (Fig. 5B).
These granules were sometimes observed in close con-
tact with the plasma membrane, which was always nega-
tive for TH immunoreactivity (Fig. 5C).
Flow cytometry analysis of TH expression
MFI in TH-labelled PBMCs was 0.468±0.210 (n=14) and
was significantly higher than in unlabelled PBMCs
(0.176±0.030, n=14; P<0.0005 vs TH-labelled cells by
two-tailed Student’s t-test for paired data). Specific label-
ling for TH in both unstimulated and PHA-stimulated
PBMCs was evident in about half of the cells, with a high
degree of variability among different samples, from less
than 20% to more than 90% TH-positive cells. PHA-stim-
ulated PBMCs, however, showed increased TH labelling
(Fig. 6A) mainly due to the high frequency of TH-positive
cells in the S+G2/M phases of the cell cycle (Table 1). 
TH mRNA expression 
and intracellular catecholamine levels
Unstimulated PBMCs contained no detectable levels of
TH mRNA, and the catecholamines dopamine, norepi-
nephrine and epinephrine were present in low amounts,
in agreement with previous studies showing that in fresh-
ly isolated PBMCs catecholamine levels are in the range
of 0.1–1×10–12 mol/106 cells, possibly due also to uptake
of extracellular (plasma) catecholamines (Marino et al.
1999). As expected (Cosentino et al. 2002), PHA stimu-
lation induced the expression of TH mRNA, followed by
a huge enhancement of intracellular catecholamines,
which increased by 20- to 40-fold (Fig. 6B, C).
Discussion
The results of the present study provide for the first time
a direct description of the ultrastructural localization of
TH in human PBMCs. Using immunocytochemistry cou-
pled to fluorescence and electron microscopy and to flow
cytometry we have shown that TH is expressed in both
unstimulated and PHA-stimulated PBMCs. However, in
unstimulated cells TH is mainly associated with the plas-
ma membrane, while in stimulated cells it is localized in
large, dense cytoplasmic granules associated with the
Golgi apparatus, and the plasma membrane shows no de-
tectable TH immunoreactivity.
The immunoelectron-microscopic technique adopted
in this study uses a mouse anti-TH monoclonal antibody
and has been performed following the steps described by
Oomori et al. (1989) for TH staining in PC12 cells. Our
control observations performed on PC12 cells showed
results which are perfectly superimposable on the ones
by Oomori and coworkers. Moreover, the absence of di-
aminobenzidine deposition in both negative and isotypic
control specimens indicates the absence of cross-reactiv-
ity with non-specific binding sites on PBMCs or PC12
cells, further supporting the specificity of TH immunore-
activity in labelled samples.
Recently, TH expression in human PBMCs was dem-
onstrated by use of an immunofluorescence technique
(Amenta et al. 2001). However, the subcellular localiza-
tion of the enzyme can be revealed only by immunoelec-
tron-microscopic investigation. Indeed, although in our
experiments light-microscopic examination suggested a
different arrangement of TH in PBMCs before and after
stimulation with PHA (inasmuch as specific fluorescence
was restricted to the plasma membrane of unstimulated
cells, but was diffused to the cytoplasm and possibly lo-
calized to small granules in stimulated cells), such differ-
ences could be confirmed and described in detail only by
ultrastructural analysis.
When examined by immunoelectron microscopy, un-
stimulated PBMCs showed an evident electron-dense
positivity localized to the plasma membrane and to the
underlying very thin cisternae pertaining to the smooth
reticulum. Such membrane-localized positivity com-
pletely disappeared in PHA-stimulated PBMCs. In these
conditions, specific immunoreactivity for TH was local-
ized exclusively to large cytoplasmic granules. Compari-
son of TH-positive granules in PHA-stimulated PBMCs
and in PC12 cells shows some remarkable similarities,
inasmuch as in both cell types the granules lie prevalent-
ly at the periphery of the cell, sometimes in direct con-
tact with the plasma membrane. Nevertheless, in PBMCs
the diameter of TH-positive granules ranges from 300 to
500 nm while in PC12 cells it lies between 100 and
200 nm. Oomori et al. (1989) suggested that in rat adre-
nal chromaffin and PC12 cells TH may co-localize with
catecholamines in the same granules, a hypothesis which
could provide the structural basis for the well-document-
ed catecholamine-dependent regulation of TH activity.
We have no direct evidence that TH-positive granules in
PBMCs also contain catecholamines. However, in line
with previous recent observations (Cosentino et al.
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Table 1 Flow cytometry 
analysis of TH expression in
human PBMCs. Values are
means ± SD of ten observa-
tions. For further details, 
see text
TH expression Unstimulated PHA-stimulated P
(G0/G1 
Total G0/G1 S+G2/M vs S+G2/M)
Fluorescence ratio 2.626±1.032 3.930±2.524 3.531±2.568 3.933±3.080 NS
Positive cells (%) 46.2±33.7 50.2±25.6 43.6±27.6 82.7±15.6 <0.005
2002), our results clearly show that PHA stimulation in-
duced a 20- to 40-fold enhancement of intracellular cate-
cholamines, together with the expression of TH mRNA.
Intracellular catecholamine content peaked at 48 h and
did not increase further, while extracellular catechol-
amine levels in the culture medium were not affected by
PHA, suggesting that catecholamines were stored in the
cells and did not undergo immediate release. As dis-
cussed above (see “Introduction”), in catecholamine-pro-
ducing cells modifications of TH activity are accompa-
nied by intracellular redistribution of the enzyme. Our
observations now offer direct support for the hypothesis
that even in immune cells TH may exist in different
functional states in relationship with its ultrastructural
localization. As a working hypothesis, we propose that
during PBMC activation TH is upregulated at different
levels, including gene transcription and enzymatic activi-
ty, thus resulting in increased synthesis of catechola-
mines. Newly synthesized catecholamines in turn colo-
calize with TH in cytoplasmic granules, where catechol-
amine accumulation might eventually result in inhibition
of TH activity.
Provided that TH-positive granules represent storage
sites for catecholamines, the question arises whether
morphological differences between PBMCs and PC12
cells may imply the existence of distinct mechanisms
regulating catecholamine release. Catecholamine release
from neurons and neuroendocrine cells occurs through
both exocytotic, Ca2+-dependent and non-exocytotic,
transporter-mediated mechanisms. In PC12 cells, regu-
lated release of catecholamines classically involves rap-
id, local rises of intracellular Ca2+ concentrations due to
Ca2+ influx through voltage-gated Ca2+ channels, and
TH-positive granules near the plasma membrane may
therefore represent a readily releasable pool in response
to cell depolarization. TH-positive granules in PBMCs,
however, differ from those in PC12 cells as regards both
size and localization. Differences in the activity of the
enzyme and in the conditions of release of granular con-
tents cannot therefore be ruled out. In any case, the loss
of TH positivity of the plasma membrane in PHA-stimu-
lated PBMCs needs further investigation to assess its
functional implications. In preliminary experiments we
have found that in PBMCs Ca2+ ionophores such as ion-
omycin and A23187 do not induce catecholamine release
(unpublished observations). It was previously shown that
unstimulated PBMCs release catecholamines in the pres-
ence of reserpine (Marino et al. 1999; Cosentino et al.
2000), supporting the existence and the functional rele-
vance of monoamine transporters. Indeed, dopamine
plasma membrane and vesicular transporters have been
recently identified in human peripheral blood lympho-
cytes (Amenta et al. 2001).
TH was found to be expressed in only 46–50% of total
PBMCs, and stimulation with PHA did not significantly
affect the proportion of TH-positive cells. Such a distri-
bution was evident even by light- and electron-micro-
scopic examination and was unequivocally confirmed by
flow cytometry analysis. This finding suggests that TH
expression (and the subsequent ability to produce cate-
cholamines) may be restricted to one or more cell sub-
set(s), in agreement with previous studies showing that
different leucocyte subpopulations and haematopoietic
cell lines may contain catecholamines to a different ex-
tent (Bergquist et al. 1998; Cosentino et al. 2000). Identi-
fication of the specific type of TH-positive cells was be-
yond the purpose of this study. PBMCs are indeed hetero-
geneous in nature as they contain both T- and B-lympho-
cytes as well as a variable proportion of monocytes. Al-
though in our conditions lymphocytes and monocytes
were always about 80% and 16% respectively, the vari-
ous experimental procedures, including isolation, culture,
stimulation and processing, profoundly affected their ul-
trastructural morphology. Microscopic examination there-
fore did not allow the unequivocal identification of the
cells. In this regard, we have currently undertaken specif-
ic experiments by use of immunomagnetic cell sorting, as
it is possible that differences in TH expression and/or cat-
echolamine levels may imply differences in the function-
al role of catecholamines in distinct cell subsets.
Interestingly, in PHA-stimulated PBMCs there was a
clear relationship between TH expression and cell prolif-
eration, TH being expressed with greater frequency in
cells in the S-G2/M phases of the cell cycle. It was re-
cently shown that in immune cell lines TH expression
correlated with cell growth (Tsao et al. 1998), and in
mouse bone marrow norepinephrine content was posi-
tively associated with the proportion of cells in the 
S-G2/M phases of the cell cycle (Maestroni et al. 1998).
These observations strengthen the hypothesis that cate-
cholamines may play a role in the functional modulation
of proliferating immune cells.
In conclusion, we have shown for the first time in hu-
man PBMCs the ultrastructural localization of TH, the
rate-limiting enzyme in the synthesis of catecholamines.
The rearrangements occurring in stimulated cells strong-
ly support the functional relevance of catecholaminergic
mechanisms during cell activation. Studies are in pro-
gress to assess the role of immune-cell-derived cate-
cholamines in the regulation of cell-cell interactions in
the immune system and in the cross-talk between the im-
mune system and the nervous system both in health and
in disease conditions.
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